SUV39H1 and glioblastoma: While SUV39H1 was not prognostic in the TCGA GBM cohort (P = 0.4849; Supplemental Figure 6), high expression was associated with poorer prognosis in the Gravendeel GBM dataset (P = 0.0045; Figure 9H).